NIH gives Altravax $3.45 mn to make AIDS vaccine
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 04 Dec, 2012
Singapore: Altravax has been awarded two research grants worth a total of $3.45 million from the NIH's National Institut...Read more
Aeras, Oxford Uni, Okairos club $2.9 mn on TB, HIV, Malaria vaccine
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a bioph...Read more
BioDiem expands antimicrobial profile
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Infectious disease therapies developer, BioDiem has expanded its local partnership network by signing an agre...Read more
NIH develops groundbreaking dengue vaccine
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 25 Jan, 2013
Singapore: A dengue vaccine candidate developed by the National Institutes of Health (NIH) has shown to be safe and has ...Read more
GSK's malaria vaccine might be reality in two years
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: The results of the phase III clinical trials of a malaria vaccine being developed by British pharmaceutical m...Read more
Sanofi working to bring dengue under control
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2014
Singapore: Sanofi announced that the phase III clinical trials for its dengue vaccine was successful, in a press confere...Read more
CSL Biotherapies awarded Pandemic Preparedness Contract by US Government
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: CSL Biotherapies has been awarded by the United States (US) Department of Health and Human Services to supply...Read more
Serum Institute acquires Dutch biologics company
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2012
Mumbai: Serum Institute of India, the flagship company of the over $1 bn Poonawalla Group and India's largest vaccine co...Read more
Mitsubishi to acquire Medicago at $1.16 per share
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2013
Singapore: Medicago, a biopharmaceutical company focused on developing highly effective and competitive vaccines based o...Read more
H7N9 claims more lives in China
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 20 Feb, 2014
Singapore: Hong Kong's Centre for Health Protection (CHP) and the provincial health department have reported eight new h...Read more
Vaccines do not cause autism: Study
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 30 May, 2014
Singapore: Researchers from the University of Sydney, have dismissed any link between development of autism and childho...Read more
EU join hands to develop personalized cancer vaccines
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Europe has established Glioma Actively Personalized Vaccine Consortium, (GAPVAC), a project designed to creat...Read more
Focus on needs of society: Dr Weidong Yin
Vaccines | Influencers | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2012
Dr Weidong Yin, the man behind Sinovac, was honoured with BioSpectrum Asia Pacific Bioscience Industry Entrepreneur of t...Read more
Panacea gets govt order worth $34 million
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 17 Dec, 2012
New Delhi: India's second largest producer of vaccines, New Delhi-based Panacea Biotec, has received a government order ...Read more
Emergent to market VaxInnate flu vaccine
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 31 Dec, 2012
Singapore: Emergent BioSolutions has signed a license agreement with VaxInnate under which Emergent acquired the exclusi...Read more
WHO: Bird flu is back in China
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 02 Apr, 2013
Singapore: Three cases of human infection with influenza A (H7N9) has erupted in China, notified China Health and Family...Read more
FDA approves Flucelvax, a cell-culture vaccine against seasonal influenza
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: US Food and Drug Administration (FDA) has approved Flucelvax (Influenza Virus Vaccine), the first cell-cultur...Read more
Takeda acquires LigoCyte Pharmaceuticals at $60 mn
Vaccines | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end ...Read more